(Received for publication, July 2, 1996, and in revised form, September 17, 1996)
From the Environmental Toxicology Graduate Program, University of California, Riverside, California 92521
We recently showed that hepatocyte nuclear factor
4 (HNF-4) defines a unique subclass of nuclear receptors that exist in
solution and bind DNA elements as homodimers (Jiang, G., Nepomuceno,
L., Hopkins, K., and Sladek, F. M. (1995) Mol. Cell. Biol.
15, 5131-5143). In this study, we show that the dimerization domains
of HNF-4 map to both the DNA binding and the ligand binding domain.
Whereas the latter is critical for dimerization in solution, the DNA
binding domain mediates cooperative, specific binding to direct repeats of AGGTCA separated by one or two nucleotides. Whereas amino acid residues 117-125 (the T-box/third helix region) are insufficient for
cooperative homodimerization and high affinity DNA binding, residues
126-142 (encompassing the A-box region) are required. Finally, in
contrast to the full-length receptor, the DNA binding domain of HNF-4
is capable of heterodimerizing with that of the retinoid X receptor but not with that of other receptors. These results indicate that the
HNF-4 DNA binding domain is distinct from that of other receptors and
that the determinants that prevent HNF-4 from heterodimerizing with RXR
lie outside the DNA binding domain, presumably in the ligand binding
domain.
Dimerization plays an important role in the function of many different types of proteins. From extracellular receptors to nuclear proteins, the ability to dimerize adds diversity as well as specificity to a variety of biological pathways. This is particularly true for the superfamily of ligand-dependent transcription factors. This family of soluble, nuclear receptors contains over 150 members, including the steroid, thyroid hormone, vitamin A, and vitamin D receptors, and an even larger number of orphan receptors for which ligands have not yet been identified (23).
The nuclear receptor superfamily is characterized by two highly conserved domains. The DNA binding domain (DBD),1 in the N-terminal half of the protein, consists of approximately 60-90 amino acids that form two zinc finger modules followed by a C-terminal extension. The so-called ligand binding domain (LBD) in the C-terminal half of the protein consists of approximately 200 amino acids. This region performs a variety of functions including transactivation, ligand binding, and protein dimerization via heptad repeats of hydrophobic residues (7, 8, 23).
With a few exceptions, the nuclear receptors all have the capacity to bind DNA as dimers. Several, particularly those related to the retinoid receptors, also bind DNA preferentially as heterodimers. Retinoid X receptor (RXR) is the most promiscuous of the receptors, dimerizing with at least 10 different receptors on a variety of DNA elements (23). Full-length RXR, in fact, binds DNA only poorly as a homodimer and not at all as a monomer (42).
Dimerization domains in the receptors have been localized to both the
DBD and the LBD using mutagenesis studies (5, 7, 8, 15, 40, 41, 43).
Dimerization interfaces have also been visualized in the
three-dimensional structures of homo- and heterodimeric complexes of
DBDs of various receptors bound to DNA: a homodimer of the estrogen
receptor (30), a homodimer of the glucocorticoid receptor (21), and a
heterodimer of RXR and the thyroid hormone receptor
(TR
)
(28). The structure of a homodimer of the LBD of RXR
, in the absence
of ligand, has also been solved and shown to contain a dimerization
interface (3). Nevertheless, the precise role of the different
dimerization motifs in DNA binding and other receptor functions has not
been clearly defined.
Hepatocyte nuclear factor 4 (HNF-4) is a highly conserved receptor essential for development in organisms ranging from insect to man (4, 34, 44). Found predominantly in the liver, kidney, and intestine, HNF-4 transcriptionally activates a wide variety of genes including those involved in fatty acid and cholesterol metabolism, glucose metabolism, urea biosynthesis, blood coagulation, hepatitis B infections, and liver differentiation (reviewed in Refs. 32, 33). A ligand, however, has not yet been identified for HNF-4. (The term ligand binding domain (LBD), however, will be used for the sake of consistency with other receptors.)
We recently showed that HNF-4, while very similar in DNA binding
specificity and amino acid sequence to RXR, does not heterodimerize with full-length RXR or any other receptor analyzed. In fact, full-length HNF-4 bound DNA only as a homodimer and sedimented as a
homodimer during glycerol gradient centrifugation. The strong homodimerization activity, as well as the exclusively nuclear localization of HNF-4, led us to conclude that HNF-4 defines a new
subclass of receptors (12).
In this study, we analyze in greater detail the mechanism of
dimerization of HNF-4 with the goal of deciphering the role and the
determinants of homo- versus heterodimerization among the nuclear receptors. The dimerization domains of HNF-4 are localized to
both the DBD and the LBD, and the DBD is shown to mediate cooperative, high affinity, specific binding to DNA. The LBD, in contrast, appears
to be important for dimerization in solution. It is also shown that, in
contrast, to the full-length receptor, the HNF-4 DBD is capable of
heterodimerizing with the DBD of RXR, although not with the DBDs of
the retinoid acid receptor
(RAR
) or thyroid hormone receptor
(TR
). These results confirm the unique nature of HNF-4 and implicate
the LBD as the major determinant of homo- versus
heterodimerization of HNF-4.
Expression vector pMT7 was
constructed by inserting double-stranded oligonucleotide MT7 (top
strand: 5-GTAATACGACTCACTATAGGGCCC
GCG-3
; bottom
strand:
5
-AATTCGC
GGGCCCTATAGTGAGTCGTATTACTGCA-3
) containing the T7 promoter and unique XhoI sites
(underlined) into the parental vector pMT2 (13) and verified by dideoxy
sequencing. pMT7 was used for in vivo expression of proteins
in COS-7 cells and in vitro expression of proteins using
reticulocyte lysate.
cDNAs encoding full-length and truncated rat HNF-4 proteins were
prepared by the polymerase chain reaction (PCR) using as template the
original HNF-4 clone pf7 (34), appropriate kinased oligonucleotides as
primers, and Vent DNA Polymerase (New England BioLabs). The PCR
products were gel-purified and subcloned into the pMT7 vector cut with
EcoRI, filled-in with Klenow, and dephosphorylated. The
sequence of the inserts were verified by dideoxy sequencing. The
N-terminal primers, N1 and N45, contain start codons, and the
C-terminal primers, C455, C374, C142, C125, C125N123E, contain stop
codons. The relative position of the primers are diagrammed in Fig. 1
and defined by the N- or C-terminal-most residue of the region to which
they anneal. N1 and C455 have been previously defined as Npf7 and Cpf7,
respectively (12). The sequence of the other primers are as
follows: N45, 5-GCCGACAT
GCTGGGTGTCAGTGCCC-3
; C374,
5
-CGG
CTAGGGCGCGTCACTGGC-3
; C142,
5
-CGG
CTAGGAGGGTAGGCTGCTG-3
; C125,
5
-CGG
CTACCGCTCATTTTGGACGG-3
; C125N123E,
5
-TT
TACCGCTCATTTTGGACGG-3
. Restriction sites
used for cloning purpose are underlined.
Protein Expression, Purification, and Electrophoretic Mobility Shift Analysis (EMSA)
Wild-type and truncated HNF-4 proteins were overexpressed in COS-7 cells, and nuclear extracts were prepared as described previously (12). RXR.DBD, RAR.DBD, and TR.DBD were overexpressed in Escherichia coli as glutathione S-transferase fusion proteins using vectors generously provided by T. Perlmann (Karolinska Institute, Stockholm, Sweden). The fusion proteins were purified by glutathione-Sepharose columns (Sigma), and the glutathione S-transferase moiety was removed by cleavage with thrombin as described previously (26). Electrophoretic mobility shift analysis (EMSA) was performed as described previously (12, 26) and as indicated in the figure legends. The double-stranded oligonucleotides used for probes in EMSA are shown in Table I.
|
In order to locate the structural domain(s) responsible for the strong dimerization activity of HNF-4, several constructs were made and are diagrammed in Fig. 1. The constructs were overexpressed in COS cells and examined for DNA binding activity by electrophoretic mobility shift analysis (EMSA) using a variety of probes (see Table I). Since dimerization motifs had been previously mapped to both the DNA binding domain (DBD) and the ligand binding domain (LBD) of other receptors, those two domains were compared in HNF-4.
The results, depicted in Fig. 2, indicate that, as seen
previously, the full-length HNF-4 (HNF4.wt) yielded only a dimeric complex with the APF1 probe (Fig. 2, lanes 1-3). In
contrast, HNF4.142, which contains the DBD but lacks the LBD, yielded
both monomeric and dimeric binding species (lanes 4-5) (see
Fig. 3 for verification of the dimer). HNF4.374, on the
other hand, which contains both the DBD and the LBD but not the very N
or C terminus, bound DNA only as a dimer (lanes 6-7).
Furthermore, HNF4.374 dimerized with HNF4.wt, as evidenced by a shift
band of intermediate mobility (lanes 9-11), whereas
HNF4.142 did not dimerize with either HNF4.wt (lane 8) or
HNF4.374 (lane 12). These results indicate that HNF-4 contains at least two dimerization domains, one located between amino
acids 45 and 142, corresponding to the DBD, and an additional domain
located between residues 143 and 374 (i.e. the LBD), which apparently precludes monomeric binding.
The HNF-4 DBD Is Responsible for DNA Binding Specificity Whereas the LBD Is Responsible for Dimerization in Solution
Our previous results from glycerol gradient sedimentation and order of dilution experiments indicated that the full-length HNF-4 is a homodimer even in the absence of DNA, i.e. in solution (12). In order to compare the dimerization activity of the HNF-4 DBD with that of the full-length protein, the following two experiments were performed. In the first, HNF4.wt and HNF4.142 were compared for cooperative binding to DNA. A saturation curve was calculated by performing EMSA with increasing amounts of COS cell nuclear extract containing either HNF4.wt or HNF4.142 and a constant amount of 32P-APF1 as probe. The results, shown in Fig. 3, demonstrate that the saturation curve of the HNF4.142 dimer is sigmoidal, whereas that of the HNF4.wt dimer is hyperbolic. The sigmoidal shape indicates that the two subunits of the HNF4.142 dimer bind DNA in a cooperative, and thus two-step, fashion. This verifies the shift complex as a protein dimer bound to the probe, as opposed to two monomers that happen to bind to the same DNA molecule. It also indicates that HNF4.142 exists in solution as a monomer. The hyperbolic shape of the HNF4.wt curve, on the other hand, indicates that the two subunits of the dimer bind DNA in a noncooperative, and thus single-step, fashion, verifying that HNF4.wt exists in solution as a homodimer.
The second experiment to test for dimerization activity in solution also examined DNA binding specificity. The binding activity of HNF4.wt and HNF4.142 on DNA containing either a single half-site or direct repeats separated by an increasing number of nucleotides (DR0-5) was determined. The rationale was that a protein that exists as a dimer in solution might yield a DNA complex migrating as a dimer on a single half-site, whereas a protein that exists in solution only as a monomer would not.
The results, shown in Fig. 4, panel A,
indicate that HNF4.wt binds DR1 (lanes 5-6), as expected,
as well as DR2 (lanes 7-8). There was also a low level of
binding activity on the probe containing a single half-site
(lanes 1, 2, 1a, and 2a) but none on any of the
other probes, DR3, DR4, or DR5 (lanes 9-14). The low
binding activity on the half-site is presumably due to reduced
protein-DNA contact and suggests that contacts to both half-sites are
important for binding the consensus element (DR1). No monomeric binding of HNF4.wt to the half-site was detected even on very long exposures (not shown). In contrast to HNF4.wt, HNF4.142 bound a single half-site only as a monomer (panel B, lanes 1 and 2). These
results, along with those of Fig. 3, confirm that HNF4.wt exists as a
homodimer and HNF4.142 as a monomer in solution.
The results of Fig. 4 also show that HNF4.142 binds DNA with a specificity similar to that of HNF4.wt. Both HNF4.wt and the HNF4.142 dimer bind significantly only to direct repeats separated by one or two nucleotides (DR1 and DR2, respectively) with an apparent preference for DR1 (lanes 5-8 in Panels A and B). Similar results were obtained from a competition experiment in which HNF4.142 and HNF4.wt were subjected to EMSA using as probe 32P-APF1 and 40-fold molar excess of several different unlabeled oligonucleotides containing HNF-4 binding sites. The results indicated that the oligonucleotides competed the HNF4-APF1 complex in a similar fashion for both the HNF4.DBD dimer and HNF4.wt dimer. The only difference is that the extent of competition appeared to be somewhat less for the HNF4.142 dimer than for the HNF4.wt dimer (data not shown). Since the construct containing just the DBD and the LBD, HNF4.374, showed an identical binding specificity to that of HNF4.wt, these results, together with those of Figs. 2, 3, 4, indicate that the DBD of HNF-4 is primarily responsible for the DNA binding specificity and partially responsible for dimerization activity on DNA. The LBD, on the other hand, is apparently responsible for the strong homodimerization activity seen in the absence of DNA.
Amino Acids 126 to 142 (encompassing the A-box Region) Is Required for Cooperative Homodimerization and Specific and High Affinity Binding to DNAIn addition to the highly conserved zinc finger motifs,
the DBD of many of the receptors also contains an A-box and a T-box (see Fig. 1). The A-box, which contacts the nucleotide bases flanking the core recognition sequence, is important for the high affinity binding of NGFI-B monomers and thyroid hormone receptor (TR) monomers and homodimers but not that of receptors such as RXR and retinoic acid
receptor (RAR) (16, 28, 38, 40, 41). For these receptors, the T-box
appears to be much more important for dimerization and high affinity
binding (18, 28, 40, 41). The N-terminal portion of the T-box in RXR
in particular, which forms an
-helix (the so-called third helix), is
required for homodimerization of the RXR
DBD on DR1 (18). We
therefore wished to determined which was more important for HNF-4 DBD
binding, the A-box or the T-box/third helix.
Amino acid sequence alignment, shown in Fig.
5A, indicates that the A-box of HNF-4, like
that of the other receptors, is fairly distinct compared with the A-box
of other receptors (e.g. RXR versus HNF-4) but
relatively conserved among the different species of HNF-4
(i.e. rat versus Drosophila HNF-4). The T-box of
HNF-4, on the other hand, is very similar to that of several other
receptors, particularly in the third helix region. In fact, HNF-4 is
closest to retinoid X receptor (RXR, -
, and -
) and differs
primarily by a single amino acid in this region: a negatively charged
glutamic acid (E) in RXR is replaced by an asparagine (N) at residue
123 in HNF-4. In addition to changing the net charge of the region, this single amino acid difference also appears to change the secondary structure of the region by terminating the putative helix in HNF-4 (Fig. 5B).
In order to examine the role of the A-box and the third helix region of HNF-4 in DNA binding, the constructs HNF4.125 and HNF4.N123E were prepared (see Fig. 1). Both end with residue 125 which corresponds to the end of the third helix in RXR. HNF4.N123E also contains a glutamic acid (E) in place of an asparagine (N) at position 123, rendering the region essentially identical to that of RXR. To help distinguish the different shift complexes, the HNF4.125 and HNF4.N123E constructs also both contain an intact N terminus, whereas HNF4.142 does not. (As expected, the N terminus did not affect the DNA binding and dimerization properties of HNF-4, data not shown.)
The results of EMSA using HNF4.125 and HNF4.142 are shown in Fig.
6A. Under the conditions used, HNF4.125 binds
APF1 as a monomer but not as a homodimer (lanes 1 and
2). In contrast, when HNF4.125 is mixed with extracts
containing HNF4.142, a new shift complex appears which is dependent
upon the presence of both HNF4.125 and HNF4.142 (lanes
5-14). This indicates that a HNF4.125-HNF4.142 heterodimer is
formed and suggests that residues 126 to 142, encompassing the A-box
region, contain a dimerization motif that interacts with residues
1-125. Furthermore, the HNF4.142-HNF4.125 heterodimer appears to bind
in a cooperative fashion, just as the HNF4.142 homodimer, since
increasing amounts of either HNF4.142 (lanes 5-9) or
HNF4.125 extract (lanes 10-14) lead to an increasing amount of heterodimer formation.
To determine whether residues 126-146 are also important in the specificity of binding of HNF-4 to DNA, a competition experiment was performed. The results, shown in Fig. 6B, indicate that the HNF4.142 homodimer and the HNF4.142-HNF4.125 heterodimer can both be efficiently competed by unlabeled competitor DNA, whereas neither the HNF4.142 nor the HNF4.125 monomer can be. This reinforces the notion that the dimerization mediated by residues 126-142 is important for the specific binding of the HNF-4 DBD to DNA.
To assess the role of the A-box in binding affinity, dissociation
constants (Kd) for both HNF4.142 and HNF4.125 were determined on both a DR1 and a DR2 probe and compared with that of the
RXR DBD. Since the RXR
DBD did not homodimerize on any DR2
examined, RAR
DBD and a native ApoAI site A probe, which can be
considered a DR2 (see Table I), were used. The results, shown in Fig.
7, indicate that both the HNF4.142 and the RXR.DBD homodimer bind DR1 with high affinity (Kd = 4.6 and
2.2 nM in panels A and C,
respectively). The EMSA for Fig. 7 was done at 4 °C in order to
detect the RXR and RAR homodimers. Under these conditions, a HNF4.125
homodimer shift complex was also detected, whereas it was not detected
when the reaction was performed at RT (see Fig. 6). The HNF4.125
homodimer complex, however, had a very low binding affinity as
evidenced by a nonsaturating curve (panel B). The binding of
all the DBD monomers (HNF4.142, HNF4.125, RXR, and RAR) was also
nonsaturating, yielding a straight line in each case (data not
shown).
In comparison to the DR1, binding to ApoAI (a DR2) occurred at a lower
affinity for the HNF4.142 homodimer but was comparable with that of the
RAR DBD (Kd = 32.3 and 49.3 nM in
panels D and F, respectively). Interestingly, the
affinity of the HNF4.125 homodimer for ApoAI site A was higher than
that for the DR1 (66.4 nM in panel E) but still
significantly lower than that of HNF4.142. These results show that,
unlike the full-length HNF-4 which binds DNA much more efficiently than
does either the full-length RXR or RAR homodimer (12), the HNF-4 DBD
binds DNA as a dimer with a similar affinity as the RXR and the RAR
DBD. The results also show that while amino acid residues 117-125 (the
third helix region) are insufficient for high affinity binding of the
HNF-4 DBD, the A-box region is required.
Since the HNF-4 DBD exists as a monomer in
solution, we hypothesized that, unlike the full-length receptor, it
might be able to heterodimerize with RXR. EMSA was performed as
above using the HNF-4 and RXR DBD constructs (see Fig. 1) and DR1 and
DR2 as probes. The results, shown in Fig. 8, indicate
that whereas RXR.DBD did not heterodimerize with HNF4.142 on DR1
(panel A, lane 3), it did on DR2 (panel B, lane
3). HNF4.125, in contrast, heterodimerized with RXR.DBD on both
DR1 and DR2 (lane 6 in panels A and B,
respectively). None of the HNF-4 DBD constructs (HNF4.142, HNF4.125,
and HNF4.N123E) heterodimerized with full-length RXR
(data not
shown).
In order to determine whether the third helix/T-box region facilitates
HNF-4 dimerization, EMSA was performed with RXR.DBD and extracts
containing HNF4.N123E, which theoretically contains a third helix
analogous to that of RXR (see Fig. 5). The results show that
HNF4.N123E does indeed form homo- and heterodimers somewhat more
readily than does HNF4.125 on DR1 (Fig. 8A, compare
lanes 10 and 11 to 5 and 6,
respectively). Therefore, the third helix may facilitate but is
evidently not required for homo- and heterodimerization. Interestingly,
in contrast to the APF1 probe (Fig. 6), HNF4.125 and HNF4.N123E do not
bind DR1 and DR2 as monomers, only as dimers (Fig. 8A, lanes
5 and 10; B, lanes 4 and data not
shown). The significance of this difference is not known but could be
due to different reaction conditions and/or nucleotide sequence of the
probes.
Heterodimerization of the HNF-4 DBD with other receptors was also
examined. However, in contrast to RXR.DBD, neither HNF4.142 nor
HNF4.125 nor HNF4.N123E heterodimerized with either RAR.DBD (Fig.
8C) or TR.DBD (data not shown). Of potential interest is the
observation that the amount of RAR DBD homodimer complex appears to be
reduced by the presence of the HNF4.DBD extracts (lanes 6, 9, 12). Whereas the reason for this reduction is not known, it is
doubtful that it is due to dimerization of the HNF4 and the RAR DBDs in
solution since NMR studies of several different receptor DBDs,
including RAR and RXR
, show the DBDs to exist only as monomers in
solution (11, 14, 18, 31).
The results of this study show that the DNA binding domain (DBD)
of HNF-4 readily heterodimerizes with the DBD of RXR. The results
also show that the A-box region at the C-terminal end of the DBD is
critical for the cooperative homodimerization and thus high affinity
binding of HNF-4 DBD to DNA. Finally, this is the first report of
direct evidence that HNF-4 binds DR2 elements as well as DR1 elements.
Although HNF-4 has been previously shown to bind native elements
comprised of nonconsensus half-sites separated by two nucleotides (2,
25), this is the first published report of HNF-4 binding a synthetic
DR2 element.
In contrast to the full-length HNF-4 which exists in
solution as a stable homodimer and binds DNA only as a homodimer (12), the HNF-4 DBD exists in solution as a monomer (Figs. 3 and
4B) and efficiently heterodimerizes with the DBD of RXR
(Fig. 8). These results demonstrate that the determinants responsible
for the exclusive homodimerization of HNF-4 reside outside the DBD, presumably in the LBD.
The conclusion that the LBD is crucial in mediating the exclusive
homodimerization activity of HNF-4 both in solution and on DNA is not
too surprising since the LBD is known to be important in determining
the homo- and heterodimerization properties of other members of the
nuclear receptor superfamily (reviewed in Ref. 10). For instance, the
DBDs of the steroid hormone receptors (i.e. estrogen and
glucocorticoid) exist in solution as monomers even at millimolar
concentrations (11, 31), whereas the full-length receptors exist in
solution as homodimers (7, 20, 29, 39). Mutations in the LBD,
especially the conserved ninth heptad region, have also been shown to
change the homo- and/or heterodimerization properties of nuclear
receptors such as TR, RAR, and RXR (1, 35, 43). However, this is the
first example of a DBD of a receptor forming heterodimers when the
corresponding full-length receptor forms only homodimers. These results
unequivocally implicate the LBD in determining homo- versus
heterodimerization of HNF-4. Indeed, the crystal structure of a dimer
of the LBD of RXR shows important contacts between amino acids of
opposite charge from each of the two monomers at the dimer interface
(3). Finally, since HNF-4 defines a new subclass of nuclear receptors
(12), we propose that the determinants of the strong homodimerization activity of other receptors that fall into that group, such as germ
cell nuclear factor and TAK1, will also reside within the LBD.
Of all the mammalian nuclear receptors, HNF-4 is most
similar to RXR in amino acid sequence, especially in the DBD (17). Mouse RXR is 56% identical to rat HNF-4 in the DBD. HNF-4 and RXR
also share response elements from at least six different genes
as well as a consensus site of a direct repeat of AGGTCA separated by
one nucleotide (DR1) (reviewed in Refs. 32, 33). These similarities
suggested that the structural and functional properties of the HNF-4
DBD would be similar to that of the RXR
DBD. The results from this
study show, however, that this is not the case.
First, the A- and the T-boxes appear to play different roles in the
homodimerization of the HNF-4 and the RXR DBDs. For example, the
A-box is required for the cooperative homodimerization of the HNF-4 DBD
(Figs. 6 and 7), whereas the T-box is necessary and sufficient for the
cooperative homodimerization of the RXR
DBD (18, 40, 41). Second,
the DBD of HNF-4 heterodimerizes with the RXR
DBD but not with the
RAR or the TR DBD, suggesting that the HNF-4 DBD is more like the RAR
or the TR DBD than the RXR
DBD (Fig. 8 and data not shown).
Since the HNF-4 DBD construct containing the A-box (HNF4.142) dimerizes cooperatively with the HNF-4 DBD construct lacking the A-box (HNF4.125), which by itself does not readily homodimerize (Fig. 6), it is concluded that the dimerization interface of the HNF-4 DBD homodimer is formed through the interaction between the A-box of one HNF-4 DBD and a more N-terminal region of the other HNF-4 DBD. This asymmetric nature of the HNF-4 DBD dimerization interface is consistent with arrangement of the two half-sites of the HNF-4 binding site as a direct repeat.
The finding that the A-box region is required for the cooperative
homodimerization of the HNF-4 DBD on DNA is rather unique among nuclear
receptors studied (see Table II). Although the A-box has
been shown to be important for the monomeric binding of NGFI-B and TR
(16, 38), it has been shown to not be critical for the homo- and
heterodimerization of RXR and RAR DBDs, for which the T-box is more
important (28, 40, 41). The A-box, however, was shown to be important
for the high affinity binding of the TR homodimer (16). It thus appears
that HNF-4 DBD homodimer functions in a manner similar to a TR DBD
homodimer even though it is much more similar to the RXR DBD in
amino acid sequence, particularly in the T-box region. This similarity,
however, is unexpected since HNF-4 and TR homodimers bind direct
repeats with different spacings. Whereas HNF-4 binds both DR1 and DR2
elements, TR binds DR4 elements as well as inverted repeats. And
binding of receptor dimers to direct repeats with different spacings
are expected to involve dimerization interfaces formed between
different regions of the receptors (28).
|
Despite the similar role of the A-box in HNF-4 and TR DBD
homodimerization, other evidence suggests that the structure of HNF-4
DBD is different from that of the TR DBD. First, the A-box plays
apparently different roles in the monomeric binding of the HNF-4 DBD
and the TR DBD. Whereas the A-box is absolutely required for the
monomeric binding of TR DBD (41), it appears to facilitate but is not
necessary for the monomeric binding of HNF-4 DBD (Fig. 6). Second, the
A-box of TR is required for heterodimerization with RXR but it is not
required for heterodimerization of the HNF-4 DBD (Fig. 8). Third,
structural modeling indicates that the A-box of the TR DBD will
interfere with the second zinc module of RXR DBD on DR1 and DR2
elements and therefore prevent the two DBDs from heterodimerizing on
those elements (28). In contrast, the HNF-4 DBD construct containing
the A-box (HNF4.142) heterodimerizes with the RXR DBD on DR2 (Fig.
8B). Potential steric hindrance could, however, explain why
the same HNF-4 DBD construct does not heterodimerize with RXR.DBD on
DR1 whereas the HNF-4 DBD construct lacking the A-box (HNF4.125) does
(Fig. 8A).
In conclusion, the results of this study show not only that the determinants of homo- versus heterodimerization reside within the LBD of the receptors but also that much remains to be learned about the role of the A-box and the T-box in the nuclear receptors. Furthermore, the results indicate that the dimerization interface of HNF-4 DBD is different from that of other nuclear receptors, which could explain why HNF-4, which binds DR1 and DR2, has a different DNA binding specificity than that of other receptors, including RXR, TR, and RAR, which preferentially bind DR1, DR4, and DR5, respectively. Finally, this study provides yet another example of how broad functional diversity among proteins within a highly conserved superfamily can be achieved with a minimal amount of alteration in primary amino acid sequence.